Longitude Capital Partners IV, LLC - 10%+ Owner at Lexeo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
LXEO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Longitude Capital Partners IV, LLC since 9/17/2023

Holdings reported by Longitude Capital Partners IV, LLC for Lexeo Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.57M $33.9M $13.22 Nov 7, 2023 By Longitude Venture Partners IV, L.P.
Series A convertible preferred stock 0 Nov 7, 2023 By Longitude Venture Partners IV, L.P. Common Stock
Series B convertible preferred stock 0 Nov 7, 2023 By Longitude Venture Partners IV, L.P. Common Stock

Transactions reported by Longitude Capital Partners IV, LLC for Lexeo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.